Modifications of glycans: biological significance and therapeutic opportunities

SM Muthana, CT Campbell… - ACS chemical biology, 2012 - ACS Publications
Carbohydrates play a central role in a wide range of biological processes. As with nucleic
acids and proteins, modifications of specific sites within the glycan chain can modulate a …

Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction

M Ayalew, H Le-Niculescu, DF Levey, N Jain… - Molecular …, 2012 - nature.com
We have used a translational convergent functional genomics (CFG) approach to identify
and prioritize genes involved in schizophrenia, by gene-level integration of genome-wide …

Pharmacogenomic study of side-effects for antidepressant treatment options in STAR* D

SL Clark, DE Adkins, K Aberg, JM Hettema… - Psychological …, 2012 - cambridge.org
BackgroundUnderstanding individual differences in susceptibility to antidepressant therapy
side-effects is essential to optimize the treatment of depression. MethodWe performed …

Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR* D

DE Adkins, SL Clark, K Åberg, JM Hettema… - Translational …, 2012 - nature.com
Affecting about 1 in 12 Americans annually, depression is a leading cause of the global
disease burden. While a range of effective antidepressants are now available, failure and …

Strengths and weaknesses of pharmacogenetic studies of antipsychotic drugs: the potential value of the PEPs study

S Mas, A LLerena, J Saiz, M Bernardo… - …, 2012 - Taylor & Francis
The successful application of pharmacogenetics in routine clinical practice is still a long way
from becoming a reality. In order to favor the transfer of pharmacogenetic results to clinical …

DRD1 rs4532 polymorphism: a potential pharmacogenomic marker for treatment response to antipsychotic drugs

VK Ota, LN Spíndola, A Gadelha… - Schizophrenia …, 2012 - Elsevier
We investigated the association of dopamine receptor D1 gene (DRD1) rs4532
polymorphism with antipsychotic treatment response in schizophrenia. We have analyzed …

[HTML][HTML] The pharmacogenetics of symptom response to antipsychotic drugs

GP Reynolds - Psychiatry investigation, 2012 - ncbi.nlm.nih.gov
Antipsychotic drugs are limited in their efficacy by the relatively poor response of negative
and cognitive symptoms of schizophrenia as well as by the substantial variability in …

Functional analysis of nonsynonymous single nucleotide polymorphisms in human SLC26A9

AP Chen, MH Chang, MF Romero - Human mutation, 2012 - Wiley Online Library
Slc26 anion transporters play crucial roles in transepithelial Cl− absorption and HCO3−
secretion; Slc26 protein mutations lead to several diseases. Slc26a9 functions as a Cl …

[HTML][HTML] Sulfotransferase 4A1 Haplotype 1 (SULT4A1-1) Is Associated With Decreased Hospitalization Events in Antipsychotic-Treated Patients With Schizophrenia

Q Liu, TL Ramsey, HY Meltzer, BW Massey… - The Primary Care …, 2012 - psychiatrist.com
Objective: To evaluate a common genetic variant, sulfotransferase 4A1 haplotype 1
(SULT4A1-1), as a predictor of hospitalization events due to the exacerbation of …

Functional genomics-and network-driven systems biology approaches for pharmacogenomics and toxicogenomics

X Yang, B Zhang, J Zhu - Current Drug Metabolism, 2012 - ingentaconnect.com
Recent advances in genomic technologies have enabled the identification of thousands of
genetic variations that are associated with hundreds of complex human diseases or traits in …